Summit Therapeutics(MX:SMMT)
MX$290.000.00 (0.00%)
MX:SMMT
Summit Therapeutics earnings date
MX$290.00
At close:0.00 (0.00%)
Summit Therapeutics (SMMT) Q3 2024 Earnings Report
1 Followers
MX:SMMT Q3 2024 EPS Results
- Actual EPS
- -MXN 1.48
- Consensus EPS
- -MXN 1.24
- Beat/Miss
- Missed by -MXN 0.24
- One Year Ago EPS
- -MXN 0.56
MX:SMMT Q3 2024 Revenue Results
- Actual Revenue
- MXN 0
- Expected Revenue
- MXN 0
- Beat/Miss
- Met expectations
- YoY Revenue Growth
- ―
Earnings Announcement Details
- Quarter
- Q3 2024
- Date
- 10/30/2024
- Time
- Before Open
- Conference Call
- Wednesday, October 30, 2024
MX:SMMT Upcoming Earnings
Summit Therapeutics's next earnings date is estimated for March 18, 2027, based on past reporting schedules.
Q3 2024 Earnings Call Audio
MX:SMMT Q3 2024 Earnings Call
0:00 / 0:00
Q3 2024 Earnings Slide Deck
Q3 2024 Earnings Call Summary
No earnings call summary is available for this earnings event.
MX:SMMT Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Mar 18, 2027 | 2026 (Q4) | -5.83- | -5.38 | ― | ― |
| Nov 04, 2026 | 2026 (Q3) | -5.23-4.82 | -5.75 | 16.13% (+0.93) | |
| Jul 23, 2026 | 2026 (Q2) | -5.08-5.20 | -14.1 | 63.16% (+8.91) | |
| Apr 30, 2026 | 2026 (Q1) | -4.99-4.45 | -1.67 | -166.67% (-2.78) | |
| Feb 23, 2026 | 2025 (Q4) | -1.43-5.38 | -1.48 | -262.50% (-3.90) | |
| Oct 20, 2025 | 2025 (Q3) | -1.56-5.75 | -1.48 | -287.50% (-4.27) | |
| Aug 11, 2025 | 2025 (Q2) | -1.69-14.10 | -0.93 | -1420.00% (-13.18) | |
| May 01, 2025 | 2025 (Q1) | -1.73-1.67 | -1.11 | -50.00% (-0.56) | |
| Feb 24, 2025 | 2024 (Q4) | -1.52-1.48 | -0.93 | -60.00% (-0.56) | |
| Oct 30, 2024 | 2024 (Q3) | -1.24-1.48 | -0.56 | -166.67% (-0.93) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed


